Empowered Funds LLC lifted its position in shares of Addus HomeCare Co. (NASDAQ:ADUS – Free Report) by 31.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 18,227 shares of the company’s stock after buying an additional 4,340 shares during the period. Empowered Funds LLC owned approximately 0.10% of Addus HomeCare worth $2,285,000 as of its most recent SEC filing.
A number of other institutional investors have also recently added to or reduced their stakes in ADUS. Creative Planning boosted its position in Addus HomeCare by 5.8% during the 3rd quarter. Creative Planning now owns 4,910 shares of the company’s stock worth $653,000 after purchasing an additional 267 shares during the period. Ellsworth Advisors LLC boosted its position in Addus HomeCare by 3.7% during the 3rd quarter. Ellsworth Advisors LLC now owns 5,344 shares of the company’s stock worth $711,000 after purchasing an additional 193 shares during the period. Net Worth Advisory Group purchased a new stake in Addus HomeCare during the 3rd quarter worth $356,000. Allspring Global Investments Holdings LLC boosted its position in Addus HomeCare by 48.4% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 70,231 shares of the company’s stock worth $9,343,000 after purchasing an additional 22,900 shares during the period. Finally, Argent Capital Management LLC boosted its position in Addus HomeCare by 5.2% during the 3rd quarter. Argent Capital Management LLC now owns 39,257 shares of the company’s stock worth $5,222,000 after purchasing an additional 1,947 shares during the period. 95.35% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
ADUS has been the subject of a number of research reports. Stephens upped their price target on shares of Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 6th. Royal Bank of Canada reissued an “outperform” rating and issued a $136.00 price objective on shares of Addus HomeCare in a research report on Thursday, November 14th. Macquarie reissued an “outperform” rating and issued a $139.00 price objective on shares of Addus HomeCare in a research report on Monday, November 4th. Citizens Jmp raised shares of Addus HomeCare to a “strong-buy” rating in a research report on Monday, December 16th. Finally, Oppenheimer upped their price objective on shares of Addus HomeCare from $145.00 to $150.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, eight have assigned a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Addus HomeCare presently has an average rating of “Buy” and a consensus target price of $134.22.
Addus HomeCare Stock Down 2.0 %
Addus HomeCare stock opened at $113.22 on Friday. The company’s fifty day simple moving average is $126.04 and its 200-day simple moving average is $127.04. Addus HomeCare Co. has a 12 month low of $85.94 and a 12 month high of $136.72. The stock has a market cap of $2.05 billion, a P/E ratio of 25.91, a P/E/G ratio of 1.55 and a beta of 1.00.
Insider Transactions at Addus HomeCare
In other Addus HomeCare news, EVP Roberton James Stevenson sold 2,250 shares of the stock in a transaction on Monday, December 9th. The shares were sold at an average price of $121.00, for a total value of $272,250.00. Following the sale, the executive vice president now directly owns 10,217 shares in the company, valued at approximately $1,236,257. This trade represents a 18.05 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO R Dirk Allison sold 25,000 shares of the stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the sale, the chief executive officer now directly owns 79,397 shares of the company’s stock, valued at $9,905,569.72. This represents a 23.95 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 39,750 shares of company stock worth $4,930,750. Corporate insiders own 4.60% of the company’s stock.
About Addus HomeCare
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Featured Stories
- Five stocks we like better than Addus HomeCare
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- NVIDIA’s Hidden AI Play: The Truth Behind Its WeRide Investment
- Stock Market Sectors: What Are They and How Many Are There?
- Up 50% in January, Twilio’s Pullback Is the Time to Buy
- Investing in Travel Stocks Benefits
- Watch These 3 Stocks—High Short Interest and Big Upside Potential
Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Co. (NASDAQ:ADUS – Free Report).
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.